Alex Zhavoronkov
2 stories
-
healthEli Lilly Partners with Insilico Medicine in $2.75B AI Drug Discovery Deal
Eli Lilly and Insilico Medicine have sealed a $2.75 billion partnership to accelerate AI-driven development of novel therapeutics for high-unmet medical needs.
-
healthEli Lilly Partners with Insilico for AI Drug Discovery
Lilly and Insilico extend collaboration for AI-driven drug development, with potential deal value up to $2.75 billion.